19390220

Source:http://linkedlifedata.com/resource/pubmed/id/19390220

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026336, umls-concept:C0034693, umls-concept:C0034721, umls-concept:C0128608, umls-concept:C0449258, umls-concept:C0521607, umls-concept:C1517004
pubmed:issue	2
pubmed:dateCreated	2009-5-29
pubmed:abstractText	Peritoneal fibrosis is a serious complication of peritoneal dialysis (PD). It has been reported that administration of mizoribine, an effective immunosuppressant, ameliorated renal fibrosis in a rat model of unilateral ureteral obstruction. We therefore examined the effects of mizoribine in an experimental model of peritoneal fibrosis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101159770
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Actins, http://linkedlifedata.com/resource/pubmed/chemical/Ccl2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2, http://linkedlifedata.com/resource/pubmed/chemical/Chlorhexidine, http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type III, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleosides, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/bredinin, http://linkedlifedata.com/resource/pubmed/chemical/chlorhexidine gluconate, http://linkedlifedata.com/resource/pubmed/chemical/smooth muscle actin, rat
pubmed:status	MEDLINE
pubmed:issn	1660-2129
pubmed:author	pubmed-author:ArakawaTetsujiT, pubmed-author:DoiShigehiroS, pubmed-author:ItoTakafumiT, pubmed-author:KawaiToruT, pubmed-author:KohnoNobuokiN, pubmed-author:NakashimaAyumuA, pubmed-author:TakahashiShunsukeS, pubmed-author:TakaoMasakiM, pubmed-author:TaniguchiYoshihikoY, pubmed-author:YoriokaNoriakiN
pubmed:issnType	Electronic
pubmed:volume	112
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	e59-69
pubmed:meshHeading	pubmed-meshheading:19390220-Actins, pubmed-meshheading:19390220-Animals, pubmed-meshheading:19390220-Cell Movement, pubmed-meshheading:19390220-Chemokine CCL2, pubmed-meshheading:19390220-Chlorhexidine, pubmed-meshheading:19390220-Collagen Type III, pubmed-meshheading:19390220-Disease Models, Animal, pubmed-meshheading:19390220-Disease Progression, pubmed-meshheading:19390220-Dose-Response Relationship, Drug, pubmed-meshheading:19390220-Fibrosis, pubmed-meshheading:19390220-Immunosuppressive Agents, pubmed-meshheading:19390220-Macrophages, Peritoneal, pubmed-meshheading:19390220-Peritoneal Diseases, pubmed-meshheading:19390220-Peritoneum, pubmed-meshheading:19390220-Rats, pubmed-meshheading:19390220-Rats, Wistar, pubmed-meshheading:19390220-Ribonucleosides, pubmed-meshheading:19390220-Transforming Growth Factor beta
pubmed:year	2009
pubmed:articleTitle	Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.
pubmed:affiliation	Department of Molecular and Internal Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Kasumi Minami-ku, Hiroshima, Japan.
pubmed:publicationType	Journal Article